A61K - Cooperative Patent Classification

CPC - A61K - 2013.07 - page 59
A61K 47/48384 . . . . { drug conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody
conjugates }
NOTE
-
The modifying part being an antibody or immunoglobulin bearing at
least one antigen-binding site. In A61K 47/48384 and its subgroupes,
classification being made according to the nature of the drug, i.e. the
pharmacologically or therapeutically active agent in the antibody
conjugate. If the nature of the antibody in a specific conjugate being
known, it being indicated with the corresponding A61K 47/48507
subgroup, in addition to the subgroup A61K 47/48384 characterizing
the drug. If the conjugate comprises also a polymer or a polyamino
acid, then the class A61K 47/48692 or A61K 47/487 being also given
A61K 47/48392 . . . . . { the drug being a vinca alkaloid }
A61K 47/484 . . . . . { the drug or compound being a sugar, nucleoside, nucleotide, nucleic
acid, e.g. RNA antisense }
A61K 47/48407 . . . . . . { the drug being an antibiotic, e.g. one of the antitumor antibiotics:
anthracyclins, adriamycin, doxorubicin, daunomycin }
A61K 47/48415 . . . . . { the drug being a protein or peptide, e.g. transferrin or bleomycin }
A61K 47/48423 . . . . . . { the drug being a peptidic cytokine, e.g. an interleukin or interferon }
A61K 47/4843 . . . . . . { the drug being an enzyme }
A61K 47/48438 . . . . . . { the drug being a toxin }
A61K 47/48446 . . . . . . . { the drug being a plant toxin }
A61K 47/48453 . . . . . . . . { the drug being a plant heterodimeric toxin; chains A or B
containing toxins, e.g. abrin, modeccin }
A61K 47/48461 . . . . . . . . . { the drug being ricin ( double chain ) }
A61K 47/48469 . . . . . . . . { the drug being a ribosomal inhibitory protein, ( RIP-i or RIP-II )
, e.g. Pap, gelonin, dianthin }
A61K 47/48476 . . . . . . . . . { the drug being ricin A }
A61K 47/48484 . . . . . . . { the drug being a bacterial toxin, e.g. diphteria toxin,
Pseudomonas exotoxin A }
A61K 47/48492 . . . . . . . { the drug being a fungal toxin, e.g. alpha sarcine, mitogillin,
zinniol, restrictocin }
A61K 47/485 . . . . . . . { the drug being a viral toxin }
A61K 47/48507 . . . { the modifying agent being a well defined antibody or immunoglobulin bearing
at least one antigen-binding site }
A61K 47/48515 . . . . { not used; see subgroups }
NOTE
-
According to the nature of the antibody, the appropriate A61K 47/48515
subgroup being given. If the pharmacologically or therapeutically active
agent in the antibody conjugate being known, the appropriate A61K
47/48384 subgroup being also given
A61K 47/48523 . . . . . { the antibody being against material from viruses }
A61K 47/4853 . . . . . . { the antibody being targeting a RNA virus }
A61K 47/48538 . . . . . { the antibody being targeting a material from animals or humans. }
A61K 47/48546 . . . . . { the antibody being targeting a cytokine, e.g. growth factors, VEGF, TNF,